US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist
  • 4.010
  • +0.140+3.62%
Close Jul 23 16:00 ET
  • 3.910
  • -0.100-2.49%
Post 19:04 ET
238.25MMarket Cap-7862P/E (TTM)

Aldeyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-44.10%9.39M
-31.73%42.79M
-55.48%6.1M
-35.40%9.55M
-41.62%10.34M
1.94%16.8M
11.49%62.68M
-11.08%13.7M
-4.25%14.78M
21.81%17.71M
Selling and administrative expenses
-42.34%3.21M
-13.26%13.34M
-62.00%1.8M
-20.22%2.59M
7.49%3.38M
31.02%5.57M
36.26%15.37M
84.77%4.74M
27.41%3.24M
2.46%3.14M
-General and administrative expense
-42.34%3.21M
-13.26%13.34M
-62.00%1.8M
-20.22%2.59M
7.49%3.38M
31.02%5.57M
36.26%15.37M
84.77%4.74M
27.41%3.24M
2.46%3.14M
Research and development costs
-44.97%6.18M
-37.73%29.46M
-52.04%4.3M
-39.67%6.96M
-52.21%6.96M
-8.16%11.24M
5.27%47.31M
-30.21%8.96M
-10.51%11.54M
26.98%14.57M
Operating profit
44.10%-9.39M
31.73%-42.79M
55.48%-6.1M
35.40%-9.55M
41.62%-10.34M
-1.94%-16.8M
-11.49%-62.68M
11.08%-13.7M
4.25%-14.78M
-21.81%-17.71M
Net non-operating interest income expense
10.45%1.31M
701.34%5.25M
69.24%1.34M
489.43%1.36M
2,153.50%1.36M
489.91%1.19M
142.10%655.35K
326.84%794.63K
165.38%231.33K
83.24%-66.02K
Non-operating interest income
7.83%1.81M
211.69%7.32M
48.08%1.86M
193.45%1.9M
446.72%1.88M
1,556.00%1.68M
1,167.49%2.35M
1,904.52%1.26M
993.05%648.24K
768.22%344.38K
Non-operating interest expense
1.47%498.53K
22.27%2.07M
11.60%514.26K
29.22%538.74K
28.45%527.14K
21.02%491.29K
-2.76%1.69M
11.60%460.82K
0.92%416.92K
-5.32%410.4K
Other net income (expense)
Income before tax
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
7.86%-14.55M
-19.04%-17.78M
Income tax
Net income
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
7.86%-14.55M
-19.04%-17.78M
Net income continuous Operations
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
7.86%-14.55M
-19.04%-17.78M
Minority interest income
Net income attributable to the parent company
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
7.86%-14.55M
-19.04%-17.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
7.86%-14.55M
-19.04%-17.78M
Basic earnings per share
48.15%-0.14
39.62%-0.64
63.64%-0.08
44.00%-0.14
50.00%-0.15
6.90%-0.27
0.93%-1.06
18.52%-0.22
7.41%-0.25
-7.14%-0.3
Diluted earnings per share
48.15%-0.14
39.62%-0.64
63.64%-0.08
44.00%-0.14
50.00%-0.15
6.90%-0.27
0.93%-1.06
18.52%-0.22
7.41%-0.25
-7.14%-0.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -44.10%9.39M-31.73%42.79M-55.48%6.1M-35.40%9.55M-41.62%10.34M1.94%16.8M11.49%62.68M-11.08%13.7M-4.25%14.78M21.81%17.71M
Selling and administrative expenses -42.34%3.21M-13.26%13.34M-62.00%1.8M-20.22%2.59M7.49%3.38M31.02%5.57M36.26%15.37M84.77%4.74M27.41%3.24M2.46%3.14M
-General and administrative expense -42.34%3.21M-13.26%13.34M-62.00%1.8M-20.22%2.59M7.49%3.38M31.02%5.57M36.26%15.37M84.77%4.74M27.41%3.24M2.46%3.14M
Research and development costs -44.97%6.18M-37.73%29.46M-52.04%4.3M-39.67%6.96M-52.21%6.96M-8.16%11.24M5.27%47.31M-30.21%8.96M-10.51%11.54M26.98%14.57M
Operating profit 44.10%-9.39M31.73%-42.79M55.48%-6.1M35.40%-9.55M41.62%-10.34M-1.94%-16.8M-11.49%-62.68M11.08%-13.7M4.25%-14.78M-21.81%-17.71M
Net non-operating interest income expense 10.45%1.31M701.34%5.25M69.24%1.34M489.43%1.36M2,153.50%1.36M489.91%1.19M142.10%655.35K326.84%794.63K165.38%231.33K83.24%-66.02K
Non-operating interest income 7.83%1.81M211.69%7.32M48.08%1.86M193.45%1.9M446.72%1.88M1,556.00%1.68M1,167.49%2.35M1,904.52%1.26M993.05%648.24K768.22%344.38K
Non-operating interest expense 1.47%498.53K22.27%2.07M11.60%514.26K29.22%538.74K28.45%527.14K21.02%491.29K-2.76%1.69M11.60%460.82K0.92%416.92K-5.32%410.4K
Other net income (expense)
Income before tax 48.24%-8.08M39.47%-37.54M63.16%-4.75M43.75%-8.19M49.46%-8.99M6.98%-15.62M-7.35%-62.02M18.11%-12.9M7.86%-14.55M-19.04%-17.78M
Income tax
Net income 48.24%-8.08M39.47%-37.54M63.16%-4.75M43.75%-8.19M49.46%-8.99M6.98%-15.62M-7.35%-62.02M18.11%-12.9M7.86%-14.55M-19.04%-17.78M
Net income continuous Operations 48.24%-8.08M39.47%-37.54M63.16%-4.75M43.75%-8.19M49.46%-8.99M6.98%-15.62M-7.35%-62.02M18.11%-12.9M7.86%-14.55M-19.04%-17.78M
Minority interest income
Net income attributable to the parent company 48.24%-8.08M39.47%-37.54M63.16%-4.75M43.75%-8.19M49.46%-8.99M6.98%-15.62M-7.35%-62.02M18.11%-12.9M7.86%-14.55M-19.04%-17.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 48.24%-8.08M39.47%-37.54M63.16%-4.75M43.75%-8.19M49.46%-8.99M6.98%-15.62M-7.35%-62.02M18.11%-12.9M7.86%-14.55M-19.04%-17.78M
Basic earnings per share 48.15%-0.1439.62%-0.6463.64%-0.0844.00%-0.1450.00%-0.156.90%-0.270.93%-1.0618.52%-0.227.41%-0.25-7.14%-0.3
Diluted earnings per share 48.15%-0.1439.62%-0.6463.64%-0.0844.00%-0.1450.00%-0.156.90%-0.270.93%-1.0618.52%-0.227.41%-0.25-7.14%-0.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg